{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:48:52Z","timestamp":1791362932014,"version":"4.3.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2303703"],"award-info":[{"award-number":["2022YFC2303703"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2605002"],"award-info":[{"award-number":["2023YFC2605002"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["Z221100003522022"],"award-info":[{"award-number":["Z221100003522022"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.tips.2025.04.003","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T16:06:05Z","timestamp":1747411565000},"page":"535-550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The frameshifting element in coronaviruses: structure, function, and potential as a therapeutic target"],"prefix":"10.1016","volume":"46","author":[{"given":"Qi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8993-4015","authenticated-orcid":false,"given":"Zhenming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2025.04.003_bb0005","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41580-023-00694-9","article-title":"Transcription regulation by long non-coding RNAs: mechanisms and disease relevance","volume":"25","author":"Ferrer","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tips.2025.04.003_bb0010","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41580-024-00748-6","article-title":"Identification of RNA structures and their roles in RNA functions","volume":"25","author":"Cao","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tips.2025.04.003_bb0015","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/s41587-023-02109-8","article-title":"KARR-seq reveals cellular higher-order RNA structures and RNA-RNA interactions","volume":"42","author":"Wu","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2025.04.003_bb0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41587-024-02149-8","article-title":"All-atom RNA structure determination from cryo-EM maps","volume":"43","author":"Li","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2025.04.003_bb0025","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1021\/acs.chemrev.3c00575","article-title":"RNA: the unsuspected conductor in the orchestra of macromolecular crowding","volume":"124","author":"Zacco","year":"2024","journal-title":"Chem. Rev."},{"key":"10.1016\/j.tips.2025.04.003_bb0030","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41573-022-00521-4","article-title":"Targeting RNA structures with small molecules","volume":"21","author":"Childs-Disney","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2025.04.003_bb0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41570-023-00569-9","article-title":"Small molecule approaches to targeting RNA","volume":"8","author":"Kovachka","year":"2024","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.tips.2025.04.003_bb0040","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.abf3546","article-title":"Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome","volume":"372","author":"Bhatt","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.04.003_bb0045","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","article-title":"The architecture of SARS-CoV-2 transcriptome","volume":"181","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tips.2025.04.003_bb0050","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41594-021-00653-y","article-title":"Cryo-EM and antisense targeting of the 28-kDa frameshift stimulation element from the SARS-CoV-2 RNA genome","volume":"28","author":"Zhang","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tips.2025.04.003_bb0055","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41586-020-2739-1","article-title":"The coding capacity of SARS-CoV-2","volume":"589","author":"Finkel","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.04.003_bb0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.virol.2020.12.010","article-title":"Programmed -1 ribosomal frameshifting in coronaviruses: a therapeutic target","volume":"554","author":"Kelly","year":"2021","journal-title":"Virology"},{"key":"10.1016\/j.tips.2025.04.003_bb0065","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1021\/acs.accounts.1c00316","article-title":"Targeting ribosomal frameshifting as an antiviral strategy: from HIV-1 to SARS-CoV-2","volume":"54","author":"Anokhina","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.tips.2025.04.003_bb0070","doi-asserted-by":"crossref","first-page":"10700","DOI":"10.1093\/nar\/gkad744","article-title":"1 Programmed ribosomal frameshifting in Class 2 umbravirus-like RNAs uses multiple long-distance interactions to shift between active and inactive structures and destabilize the frameshift stimulating element","volume":"51","author":"Mikkelsen","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2025.04.003_bb0075","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1128\/JVI.02480-09","article-title":"Achieving a golden mean: mechanisms by which coronaviruses ensure synthesis of the correct stoichiometric ratios of viral proteins","volume":"84","author":"Plant","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.tips.2025.04.003_bb0080","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3807","article-title":"Reprogramming eukaryotic translation with ligand-responsive synthetic RNA switches","volume":"13","author":"Anzalone","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tips.2025.04.003_bb0085","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78373","article-title":"A frameshift in time","volume":"11","author":"Yordanova","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.tips.2025.04.003_bb0090","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature04735","article-title":"A mechanical explanation of RNA pseudoknot function in programmed ribosomal frameshifting","volume":"441","author":"Namy","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.04.003_bb0095","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2221324120","article-title":"Evolution of coronavirus frameshifting elements: competing stem networks explain conservation and variability","volume":"120","author":"Yan","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2025.04.003_bb0100","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1261\/rna.2225206","article-title":"Comparative study of the effects of heptameric slippery site composition on -1 frameshifting among different eukaryotic systems","volume":"12","author":"Plant","year":"2006","journal-title":"RNA"},{"key":"10.1016\/j.tips.2025.04.003_bb0105","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.bpj.2020.10.012","article-title":"Structure-altering mutations of the SARS-CoV-2 frameshifting RNA element","volume":"120","author":"Schlick","year":"2021","journal-title":"Biophys. J."},{"key":"10.1016\/j.tips.2025.04.003_bb0110","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1021\/jacs.1c03003","article-title":"To knot or not to knot: multiple conformations of the SARS-CoV-2 frameshifting RNA element","volume":"143","author":"Schlick","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.tips.2025.04.003_bb0115","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1261\/rna.080035.124","article-title":"Abolished frameshifting for predicted structure-stabilizing SARS-CoV-2 mutants: implications to alternative conformations and their statistical structural analyses","volume":"30","author":"Dey","year":"2024","journal-title":"RNA"},{"key":"10.1016\/j.tips.2025.04.003_bb0120","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1261\/rna.076141.120","article-title":"RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look","volume":"26","author":"Rangan","year":"2020","journal-title":"RNA"},{"key":"10.1016\/j.tips.2025.04.003_bb0125","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.molcel.2020.12.041","article-title":"Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms","volume":"81","author":"Huston","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tips.2025.04.003_bb0130","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1021\/acschembio.1c00324","article-title":"The SARS-CoV-2 programmed -1 ribosomal frameshifting element crystal structure solved to 2.09 A using chaperone-assisted RNA crystallography","volume":"16","author":"Roman","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.tips.2025.04.003_bb0135","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1021\/acs.biochem.3c00716","article-title":"Structure of the SARS-CoV-2 frameshift stimulatory element with an upstream multibranch loop","volume":"63","author":"Peterson","year":"2024","journal-title":"Biochemistry"},{"key":"10.1016\/j.tips.2025.04.003_bb0140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1261\/rna.078825.121","article-title":"Crystal structure of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) frameshifting pseudoknot","volume":"28","author":"Jones","year":"2022","journal-title":"RNA"},{"key":"10.1016\/j.tips.2025.04.003_bb0145","doi-asserted-by":"crossref","first-page":"12436","DOI":"10.1093\/nar\/gkaa1053","article-title":"Genome-wide mapping of SARS-CoV-2 RNA structures identifies therapeutically-relevant elements","volume":"48","author":"Manfredonia","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2025.04.003_bb0150","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/s41467-022-28603-2","article-title":"Secondary structural ensembles of the SARS-CoV-2 RNA genome in infected cells","volume":"13","author":"Lan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2025.04.003_bb0155","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1261\/rna.2132503","article-title":"The 9-A solution: how mRNA pseudoknots promote efficient programmed -1 ribosomal frameshifting","volume":"9","author":"Plant","year":"2003","journal-title":"RNA"},{"key":"10.1016\/j.tips.2025.04.003_bb0160","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/nar\/gki329","article-title":"Torsional restraint: a new twist on frameshifting pseudoknots","volume":"33","author":"Plant","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2025.04.003_bb0165","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.cell.2014.04.041","article-title":"Programmed -1 frameshifting by kinetic partitioning during impeded translocation","volume":"157","author":"Caliskan","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.tips.2025.04.003_bb0170","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0092-8674(02)00649-9","article-title":"The ribosomal exit tunnel functions as a discriminating gate","volume":"108","author":"Nakatogawa","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.tips.2025.04.003_bb0175","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.1261909","article-title":"Ribosome. Mechanical force releases nascent chain-mediated ribosome arrest in vitro and in vivo","volume":"348","author":"Goldman","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.04.003_bb0180","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nsmb.1614","article-title":"The ribosome as a platform for co-translational processing, folding and targeting of newly synthesized proteins","volume":"16","author":"Kramer","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tips.2025.04.003_bb0185","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cell.2018.12.030","article-title":"Regulation of HIV-1 Gag-Pol expression by shiftless, an inhibitor of programmed -1 ribosomal frameshifting","volume":"176","author":"Wang","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tips.2025.04.003_bb0190","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3390\/v13071230","article-title":"Modulation of viral programmed ribosomal frameshifting and stop codon readthrough by the host restriction factor shiftless","volume":"13","author":"Napthine","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.tips.2025.04.003_bb0195","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.1038\/s41467-021-27431-0","article-title":"The short isoform of the host antiviral protein ZAP acts as an inhibitor of SARS-CoV-2 programmed ribosomal frameshifting","volume":"12","author":"Zimmer","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2025.04.003_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112987","article-title":"Genome-wide CRISPR screens identify noncanonical translation factor eIF2A as an enhancer of SARS-CoV-2 programmed -1 ribosomal frameshifting","volume":"42","author":"Wei","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2025.04.003_bb0205","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1038\/s41591-024-03217-x","article-title":"Advancing ASO therapies from development to implementation","volume":"30","author":"Schuele","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2025.04.003_bb0210","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","article-title":"Antisense technology: an overview and prospectus","volume":"20","author":"Crooke","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2025.04.003_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202409440","article-title":"Accessing therapeutically-relevant multifunctional antisense oligonucleotide conjugates using native chemical ligation","volume":"63","author":"Engelhardt","year":"2024","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.tips.2025.04.003_bb0220","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1038\/s41467-022-32216-0","article-title":"An intranasal ASO therapeutic targeting SARS-CoV-2","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2025.04.003_bb0225","doi-asserted-by":"crossref","first-page":"10497","DOI":"10.1021\/jacs.2c12488","article-title":"Triplex-forming peptide nucleic acid controls dynamic conformations of RNA bulges","volume":"145","author":"Ryan","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.tips.2025.04.003_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2011.04.009","article-title":"Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication","volume":"91","author":"Ahn","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.tips.2025.04.003_bb0235","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1021\/acs.biochem.7b00744","article-title":"Selective binding to mRNA duplex regions by chemically modified peptide nucleic acids stimulates ribosomal frameshifting","volume":"57","author":"Puah","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.tips.2025.04.003_bb0240","article-title":"Structure-based design of antisense oligonucleotides that inhibit SARS-CoV-2 replication","author":"Li","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.tips.2025.04.003_bb0245","doi-asserted-by":"crossref","first-page":"11177","DOI":"10.1093\/nar\/gkae778","article-title":"Making target sites in large structured RNAs accessible to RNA-cleaving DNAzymes through hybridization with synthetic DNA oligonucleotides","volume":"52","author":"Nurmi","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2025.04.003_bb0250","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1093\/nar\/gkac562","article-title":"Identification of nucleobase chemical modifications that reduce the hepatotoxicity of gapmer antisense oligonucleotides","volume":"50","author":"Yoshida","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2025.04.003_bb0255","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/nar\/gkad067","article-title":"Chemistry, structure and function of approved oligonucleotide therapeutics","volume":"51","author":"Egli","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2025.04.003_bb0260","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1021\/acsnano.2c09752","article-title":"An antisense oligonucleotide-loaded blood-brain barrier penetrable nanoparticle mediating recruitment of endogenous neural stem cells for the treatment of Parkinson's disease","volume":"17","author":"Sun","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.tips.2025.04.003_bb0265","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41392-022-01249-8","article-title":"Small molecules in the treatment of COVID-19","volume":"7","author":"Lei","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tips.2025.04.003_bb0270","doi-asserted-by":"crossref","first-page":"10094","DOI":"10.1021\/ja1098325","article-title":"Identification of RNA pseudoknot-binding ligand that inhibits the -1 ribosomal frameshifting of SARS-coronavirus by structure-based virtual screening","volume":"133","author":"Park","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.tips.2025.04.003_bb0275","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1021\/ja410344b","article-title":"Anti-frameshifting ligand reduces the conformational plasticity of the SARS virus pseudoknot","volume":"136","author":"Ritchie","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.tips.2025.04.003_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105452","article-title":"Geneticin shows selective antiviral activity against SARS-CoV-2 by interfering with programmed -1 ribosomal frameshifting","volume":"208","author":"Varricchio","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.tips.2025.04.003_bb0285","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1021\/acs.jcim.4c00758","article-title":"Novel inhibitors of SARS-CoV-2 RNA identified through virtual screening","volume":"64","author":"Mathez","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.tips.2025.04.003_bb0290","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41592-022-01607-y","article-title":"Learning RNA structure prediction from crowd-designed RNAs","volume":"19","author":"Anon.","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tips.2025.04.003_bb0295","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023051118","article-title":"Restriction of SARS-CoV-2 replication by targeting programmed -1 ribosomal frameshifting","volume":"118","author":"Sun","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2025.04.003_bb0300","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/v14020177","article-title":"Identifying inhibitors of -1 programmed ribosomal frameshifting in a broad spectrum of coronaviruses","volume":"14","author":"Munshi","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.tips.2025.04.003_bb0305","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/v13081639","article-title":"A novel frameshifting inhibitor having antiviral activity against zoonotic coronaviruses","volume":"13","author":"Ahn","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.tips.2025.04.003_bb0310","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s43018-020-0024-8","article-title":"Old drugs with new tricks","volume":"1","author":"Beijersbergen","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.tips.2025.04.003_bb0315","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1021\/acsmedchemlett.3c00051","article-title":"Discovery of small molecules targeting the frameshifting element RNA in SARS-CoV-2 viral genome","volume":"14","author":"Yang","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.tips.2025.04.003_bb0320","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.apsb.2024.02.023","article-title":"Carrimycin inhibits coronavirus replication by decreasing the efficiency of programmed -1 ribosomal frameshifting through directly binding to the RNA pseudoknot of viral frameshift-stimulatory element","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.tips.2025.04.003_bb0325","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-022-04537-z","article-title":"Targeting Xist with compounds that disrupt RNA structure and X inactivation","volume":"604","author":"Aguilar","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.04.003_bb0330","doi-asserted-by":"crossref","first-page":"13301","DOI":"10.1021\/acs.chemrev.4c00472","article-title":"Technologies for targeted RNA degradation and induced RNA decay","volume":"124","author":"Mikutis","year":"2024","journal-title":"Chem. Rev."},{"key":"10.1016\/j.tips.2025.04.003_bb0335","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41586-023-06091-8","article-title":"Programming inactive RNA-binding small molecules into bioactive degraders","volume":"618","author":"Tong","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.04.003_bb0340","doi-asserted-by":"crossref","first-page":"10217","DOI":"10.1021\/acs.jmedchem.2c00875","article-title":"Nucleic-acid-based targeted degradation in drug discovery","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2025.04.003_bb0345","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1021\/acscentsci.0c00984","article-title":"Targeting the SARS-CoV-2 RNA genome with small molecule binders and ribonuclease targeting chimera (RIBOTAC) degraders","volume":"6","author":"Haniff","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.tips.2025.04.003_bb0350","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1021\/acscentsci.0c01094","article-title":"meCLICK-Seq, a substrate-hijacking and RNA degradation strategy for the study of RNA methylation","volume":"6","author":"Mikutis","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.tips.2025.04.003_bb0355","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/acscentsci.3c00015","article-title":"Proximity-induced nucleic acid degrader (PINAD) approach to Targeted RNA degradation using small molecules","volume":"9","author":"Mikutis","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.tips.2025.04.003_bb0360","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41587-023-01790-z","article-title":"Drugging RNA","volume":"41","author":"Garber","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2025.04.003_bb0365","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1128\/MCB.21.24.8657-8670.2001","article-title":"Ribosomal pausing at a frameshifter RNA pseudoknot is sensitive to reading phase but shows little correlation with frameshift efficiency","volume":"21","author":"Kontos","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tips.2025.04.003_bb0370","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature10126","article-title":"The ribosome uses two active mechanisms to unwind messenger RNA during translation","volume":"475","author":"Qu","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.04.003_bb0375","doi-asserted-by":"crossref","first-page":"16167","DOI":"10.1073\/pnas.1204114109","article-title":"Programmed -1 frameshifting efficiency correlates with RNA pseudoknot conformational plasticity, not resistance to mechanical unfolding","volume":"109","author":"Ritchie","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2025.04.003_bb0380","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.100.2588.103.b","article-title":"Control of Gram-negative bacteria in experimental animals by streptomycin","volume":"100","author":"Jones","year":"1944","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.04.003_bb0385","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1073\/pnas.31.6.157","article-title":"Strain specificity and production of antibiotic substances: V. Strain resistance of bacteria to antibiotic substances, especially to streptomycin","volume":"31","author":"Waksman","year":"1945","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2025.04.003_bb0390","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/d41586-019-02554-z","article-title":"The structure of DNA","volume":"575","author":"Ferry","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.04.003_bb0395","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1126\/science.147.3664.1462","article-title":"Structure of a ribonucleic acid","volume":"147","author":"Holley","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.04.003_bb0400","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41588-024-01816-5","article-title":"RNA editing with CRISPR","volume":"56","author":"Gross","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2025.04.003_bb0405","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-024-00943-2","article-title":"Frameworks for transformational breakthroughs in RNA-based medicines","volume":"23","author":"Androsavich","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2025.04.003_bb0410","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/00003495-199957030-00010","article-title":"Fomivirsen","volume":"57","author":"Perry","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.tips.2025.04.003_bb0415","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/nat.2017.0665","article-title":"FDA approval of nusinersen for spinal muscular atrophy makes 2016 the year of splice modulating oligonucleotides","volume":"27","author":"Aartsma-Rus","year":"2017","journal-title":"Nucleic Acid. Ther."},{"key":"10.1016\/j.tips.2025.04.003_bb0420","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s40265-016-0657-1","article-title":"Eteplirsen: first global approval","volume":"76","author":"Syed","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.tips.2025.04.003_bb0425","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40265-020-01267-2","article-title":"Golodirsen: first approval","volume":"80","author":"Heo","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.tips.2025.04.003_bb0430","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nrd1677","article-title":"Pegaptanib sodium","volume":"4","author":"Fine","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2025.04.003_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.114168","article-title":"Translation of aptamers toward clinical diagnosis and commercialization","volume":"208","author":"Liu","year":"2022","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.tips.2025.04.003_bb0440","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41573-024-00912-9","article-title":"RNAi-based drug design: considerations and future directions","volume":"23","author":"Tang","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2025.04.003_bb0445","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41587-023-02105-y","article-title":"RNA interference in the era of nucleic acid therapeutics","volume":"42","author":"Jadhav","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2025.04.003_bb0450","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/d41573-021-00210-8","article-title":"RNAi drugs at \u2018a remarkable period of a renaissance\u2019","volume":"21","author":"Mullard","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2025.04.003_bb0455","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40265-018-0983-6","article-title":"Patisiran: first global approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.tips.2025.04.003_bb0460","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41587-020-00788-1","article-title":"First small-molecule drug targeting RNA gains momentum","volume":"39","author":"Sheridan","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2025.04.003_bb0465","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1021\/acsmedchemlett.0c00659","article-title":"Risdiplam, the first approved small molecule splicing modifier drug as a blueprint for future transformative medicines","volume":"12","author":"Ratni","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.tips.2025.04.003_bb0470","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1474-4422(21)00428-2","article-title":"Risdiplam: new opportunities but more to be done","volume":"21","author":"Sansone","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2025.04.003_bb0475","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41563-024-01859-3","article-title":"Special delivery","volume":"23","author":"Ball","year":"2024","journal-title":"Nat. Mater."},{"key":"10.1016\/j.tips.2025.04.003_bb0480","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1126\/science.abe5650","article-title":"Geometric deep learning of RNA structure","volume":"373","author":"Townshend","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.04.003_bb0485","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41587-023-01725-8","article-title":"Big pharma craves slice of AI-based RNA drug discovery","volume":"41","author":"Anon.","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2025.04.003_bb0490","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.medj.2024.07.026","article-title":"Accelerating drug discovery, development, and clinical trials by artificial intelligence","volume":"5","author":"Zhang","year":"2024","journal-title":"Med"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614725000690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614725000690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:15:59Z","timestamp":1762251359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614725000690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":98,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0165614725000690"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2025.04.003","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The frameshifting element in coronaviruses: structure, function, and potential as a therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2025.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}